COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH PSORIATIC ARTHRITIS (PSA) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN EUROPE

被引：0
|
作者：
Narayanan, S. [1 ]
Lu, Y. [2 ]
Hutchings, R. [2 ]
Baynton, E. [2 ]
机构：
[1] Ipsos Healthcare, Columbia, MD USA
[2] Ipsos Healthcare, London, England
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2574
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS4
引用
收藏
页码：A373 / A373
页数：1
相关论文
共 50 条
  • [41] Etanercept in patients with psoriatic arthritis: Sustained improvement in skin and joint disease
    Goffe, BS
    Gottlieb, A
    Lebwohl, M
    Zitnik, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P55 - P55
  • [42] Non-trough serum drug levels of adalimumab and etanercept are associated with response in patients with psoriatic arthritis
    Curry, Philippa D. K.
    Hum, Ryan M.
    Morris, Andrew P.
    Jani, Meghna
    Chinoy, Hector
    Barton, Anne
    Bluett, James
    RHEUMATOLOGY, 2023,
  • [43] Patient-reported outcomes in a randomized comparison of etanercept and placebo for treatment of psoriatic arthritis
    Mease, P. J.
    Woolley, M.
    Singh, A.
    Tsuji, W.
    Dunn, M.
    Chiou, C. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 535 - 535
  • [44] Pharmacological Monitoring of Adalimumab and Etanercept-Treated Psoriatic Arthritis Patients in Predicting Future Treatment Response
    Jani, Meghna
    Chinoy, Hector
    Barton, Anne
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [45] LONG-TERM EFFICACY OF ADALIMUMAB AND ETANERCEPT IN PSORIATIC ARTHRITIS PATIENTS: PROLONGED INTERVALS BETWEEN INJECTIONS
    Lorenzin, M.
    Ramonda, R.
    Modesti, V.
    Ortolan, A.
    Frallonardo, P.
    Punzi, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 948 - 948
  • [46] An Examination of Patient-Reported Outcomes Data from a Randomized Trial Examining Etanercept and Methotrexate as Monotherapy or in Combination in Patients with Psoriatic Arthritis
    Strand, Vibeke
    Mease, Philip
    Maksabedian, Ervant
    Stolshek, Bradley
    Liu, Lyrica
    Collier, David
    Kricorian, Gregory
    Merola, Joseph
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [47] Outcomes in Patients with Rheumatoid Arthritis Initiating Therapy with Etanercept, Adalimumab, or Janus Kinase Inhibitors
    Pappas, Dimitrios
    O'Brien, Jacqueline
    Guo, Lin
    Shan, Ying
    Baker, Joshua
    Kricorian, Gregory
    Stryker, Scott
    Collier, David
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 856 - 857
  • [48] OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING THERAPY WITH ETANERCEPT, ADALIMUMAB, OR JANUS KINASE INHIBITORS
    Pappas, D. A.
    O'brien, J.
    Guo, L.
    Shan, Y.
    Baker, J.
    Kricorian, G.
    Stryker, S.
    Collier, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 529 - 530
  • [49] The Psoriatic Arthritis Screening Questionnaire( PASQ) Continues to Identify Psoriatic Arthritis (PsA) Patients With Change in Disease Activity
    Khraishi, Majed
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1334 - 1335
  • [50] Comparison of patient-physician perceptions of disease activity in psoriatic arthritis (PsA)
    Schentag, C
    Gladman, D
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 404 - 404
12345